Seemungal TA, Harper-Owen R, Bhowmik A, et al. 2000. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease. Eur Respir J, 16:677-83. Senderovitz T, Vestbo J, Frandsen J, et al. 1999. Steroid reversibility test followed by inhaled budesonide or placebo in outpatients with stable chronic obstructive pulmonary disease. The Danish Society of Respiratory Medicine. Respir Med, 93:715-18. Shepperd S, Harwood D, Gray A, et al. 1998. Randomised controlled trial comparing hospital at home care with inpatient hospital care. II: cost minimisation analysis. BMJ, 316:1791-6. Shepperd S, Harwood D, Jenkinson C, et al. 1998. Randomised controlled trial comparing hospital at home care with inpatient hospital care. I: three month follow up of health outcomes. BMJ, 316:1786-91. Siafakas NM, Vermeire P, Pride NB, et al. 1995. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J, 8:1398-420. Sin DD, Tu JV. 2001. Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 164:580-4. Sin DD, Wu L, Anderson JA, et al. 2005. Inhaled corticosteroids and mortal- ity in chronic obstructive pulmonary disease. Thorax, 60:992-7. Skwarska E, Cohen G, Skwarski KM, et al. 2000. Randomized controlled trial of supported discharge in patients with exacerbations of chronic obstructive pulmonary disease. Thorax, 55:907-12. Soderling SH, Beavo JA. 2000. Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions. Curr Opin Cell Biol, 12:174-9. Soler N, Torres A, Ewig S, et al. 1998. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med, 157:1498-505. Soriano JB, Vestbo J, Pride NB, et al. 2002. Survival in COPD patients after regular use of ﬂuticasone propionate and salmeterol in general practice. Eur Respir J, 20:819-25. Suissa F. 2003. Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies. Am J Respir Crit Care Med, 168:49-53. Szafranski W, Cukier A, Ramirez A, et al. 2003. Efﬁcacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Eur Respir J, 21:74-81. Pharmacological treatment of COPD Tashkin D, Kanner R, Bailey W, et al. 2001. Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo- controlled, randomised trial. Lancet, 357:1571-5. Thompson WH, Nielson CP, Carvalho P, et al. 1996. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. Am J Respir Crit Care Med, 154:407-12. Torphy TJ, Undem BJ, Cieslinski LB, et al. 1993. Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle. J Pharmacol Exp Ther, 265:1213-23. Ulrik CS. 1995. Efﬁcacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study. Thorax, 50:750-4. Undem, JB, Lichtenstein LM. 2001. Drugs used in the treatment of asthma. In: Hardman JG, Limbird LE, Goodman Gilman A (ed). The pharma- cological basis of therapeutics. 10th edn. New York: McGraw-Hill, 733-54. van Noord JA, Aumann JL, Janssens E, et al. 2006. Effects of tiotropium with and without formoterol on airﬂow obstruction and resting hyperinﬂation in patients with COPD. Chest, 129:509-17. van Noord JA, de Munck DR, Bantje TA, et al. 2000. Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium. Eur Respir J, 15:878-85. van Schayck CP, Dompeling E, van Herwaarden CL, et al. 1991. Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study. BMJ, 303:1426-31. Vathenen AS, Britton JR, Ebden P, et al. 1988. High-dose inhaled albuterol in severe chronic airﬂow limitation. Am Rev Respir Dis, 138:850-5. Vestbo J, Sorensen T, Lange P, et al. 1999. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet, 353:1819-23. Vestbo J; TORCH Study Group. 2004. The TORCH (towards a revolution in COPD health) survival study protocol. Eur Respir J, 24:206-10. Wouters EF, Postma DS, Fokkens B, et al. 2005. Withdrawal of ﬂuticasone propionate from combined salmeterol/ﬂuticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomized controlled trial. Thorax, 60:480-7. International Journal of COPD 2006:1(4) 423